| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |